MyFinsight
Home
Blog
About
Maturity of short-term
investments
$32,789K
(-80.79%↓ Y/Y)
Proceeds from sale of
property, plant and...
$17K
Net cash provided by
investing activities
$15,490K
(-85.19%↓ Y/Y)
Canceled cashflow
$17,316K
Net (decrease)
increase in cash and cash...
$2,693K
(-82.77%↓ Y/Y)
Canceled cashflow
$12,797K
Purchase of short-term
investments
$17,316K
(-73.67%↓ Y/Y)
Accrued liabilities
$4,422K
(151.29%↑ Y/Y)
Stock-based compensation
expense
$4,187K
(-72.62%↓ Y/Y)
Accounts payable
$1,169K
(125.52%↑ Y/Y)
Non-cash operating lease
expense
$842K
(-48.28%↓ Y/Y)
Depreciation expense
$249K
(-72.18%↓ Y/Y)
Net cash used in
operating activities
-$12,797K
(85.70%↑ Y/Y)
Canceled cashflow
$10,869K
Net loss
-$22,371K
(77.51%↑ Y/Y)
Prepaid expenses and
other current assets
$943K
(147.87%↑ Y/Y)
Other non-current
assets
$192K
(546.51%↑ Y/Y)
Net amortization
(accretion) on short-term...
$118K
(103.53%↑ Y/Y)
Operating lease
liabilities
-$42K
(-220.00%↓ Y/Y)
Back
Back
Cash Flow
PLIANT THERAPEUTICS, INC. (PLRX)
PLIANT THERAPEUTICS, INC. (PLRX)
source: myfinsight.com